{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:19:20Z","timestamp":1781669960025,"version":"3.54.5"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.canlet.2024.217302","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T19:48:17Z","timestamp":1729280897000},"page":"217302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Histone deacetylase upregulation of neuropilin-1 in osteosarcoma is essential for pulmonary metastasis"],"prefix":"10.1016","volume":"606","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8808-2220","authenticated-orcid":false,"given":"Niveditha","family":"Nerlakanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3439-8227","authenticated-orcid":false,"given":"Jeremy J.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan T.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa M.","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2681-0429","authenticated-orcid":false,"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8238-2465","authenticated-orcid":false,"given":"Damon R.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor C.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.canlet.2024.217302_bib1","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/cncr.24121","article-title":"Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program","volume":"115","author":"Mirabello","year":"2009","journal-title":"Cancer: Interdisciplin. Int. J. Am. Cancer Soc."},{"issue":"6","key":"10.1016\/j.canlet.2024.217302_bib2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/jso.21140","article-title":"High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions","volume":"98","author":"Bacci","year":"2008","journal-title":"J. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.canlet.2024.217302_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.2008.16.2305","article-title":"Second and subsequent recurrences of osteosarcoma: presentation, treatment, and outcomes of 249 consecutive cooperative osteosarcoma study group patients","volume":"27","author":"Bielack","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.canlet.2024.217302_bib4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1586\/14737140.2016.1168697","article-title":"Metastatic osteosarcoma: a challenging multidisciplinary treatment","volume":"16","author":"Meazza","year":"2016","journal-title":"Expet Rev. Anticancer Ther."},{"issue":"25","key":"10.1016\/j.canlet.2024.217302_bib5","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM198606193142502","article-title":"The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity","volume":"314","author":"Link","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2024.217302_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejca.2018.11.027","article-title":"Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort","volume":"109","author":"Smeland","year":"2019","journal-title":"Eur. J. Cancer"},{"issue":"10","key":"10.1016\/j.canlet.2024.217302_bib7","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1200\/JCO.2003.08.132","article-title":"Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols","volume":"21","author":"Kager","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2024.217302_bib8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/pbc.25754","article-title":"Rapid protocol enrollment in osteosarcoma: a report from the Children's Oncology Group","volume":"63","author":"Isakoff","year":"2016","journal-title":"Pediatr. Blood Cancer"},{"issue":"2_Supplement_2","key":"10.1016\/j.canlet.2024.217302_bib9","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.METASTASIS22-A024","article-title":"Abstract A024: a potent eIF4A1\/2 inhibitor CR-1-31B down-modulates the antioxidant stress response in osteosarcoma cells and inhibits in vivo lung metastases","volume":"83","author":"Lizardo","year":"2023","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2024.217302_bib10","article-title":"Progress in sarcomas: highlights from the 2023 annual meetingof the connective tissue oncology society","volume":"32","author":"Cripe","year":"2024","journal-title":"Molecul. Ther. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217302_bib11","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s13402-023-00867-w","article-title":"Host-derived growth factors drive ERK phosphorylation and MCL1 expression to promote osteosarcoma cell survival during metastatic lung colonization","volume":"47","author":"McAloney","year":"2024","journal-title":"Cell. Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2024.217302_bib12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nm.4475","article-title":"Positively selected enhancer elements endow osteosarcoma cells with metastatic competence","volume":"24","author":"Morrow","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.canlet.2024.217302_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12915-023-01593-3","article-title":"Osteosarcoma tumors maintain intra-tumoral transcriptional heterogeneity during bone and lung colonization","volume":"21","author":"Rajan","year":"2023","journal-title":"BMC Biol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217302_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/srep16991","article-title":"Identification of synergistic, clinically achievable, combination therapies for osteosarcoma","volume":"5","author":"Yu","year":"2015","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.canlet.2024.217302_bib15","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1002\/ijc.33046","article-title":"Histone deacetylase inhibition prevents the growth of primary and metastatic osteosarcoma","volume":"147","author":"McGuire","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2024.217302_bib16","first-page":"269","article-title":"Panobinostat for the treatment of multiple myeloma: the evidence to date","author":"Bailey","year":"2015","journal-title":"Hematol. Res. Rev."},{"issue":"6","key":"10.1016\/j.canlet.2024.217302_bib17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2217\/fon-2016-0329","article-title":"Panobinostat for the management of multiple myeloma","volume":"13","author":"Sivaraj","year":"2017","journal-title":"Future Oncol."},{"issue":"8","key":"10.1016\/j.canlet.2024.217302_bib18","first-page":"859","article-title":"The discovery and development of romidepsin for the treatment of T-cell lymphoma","volume":"12","author":"Smolewski","year":"2017","journal-title":"Expet Opin. Drug Discov."},{"issue":"4","key":"10.1016\/j.canlet.2024.217302_bib19","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0092-8674(00)80535-8","article-title":"Neuropilin is a semaphorin III receptor","volume":"90","author":"Kolodkin","year":"1997","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.canlet.2024.217302_bib20","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0896-6273(00)80626-1","article-title":"Neuropilin-1 extracellular domains mediate semaphorin D\/III-induced growth cone collapse","volume":"21","author":"Nakamura","year":"1998","journal-title":"Neuron"},{"issue":"6","key":"10.1016\/j.canlet.2024.217302_bib21","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0092-8674(00)81402-6","article-title":"Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor","volume":"92","author":"Soker","year":"1998","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.canlet.2024.217302_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2613.1998.700404.x","article-title":"The vascular endothelial growth factor family; proteins which guide the development of the vasculature","volume":"79","author":"Achen","year":"1998","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.canlet.2024.217302_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-016-0291-5","article-title":"Neuropilin-1 is associated with clinicopathology of gastric cancer and contributes to cell proliferation and migration as multifunctional co-receptors","volume":"35","author":"Li","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"22","key":"10.1016\/j.canlet.2024.217302_bib24","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1158\/0008-5472.CAN-12-0995","article-title":"Neuropilin-1\u2013dependent regulation of EGF-receptor signaling","volume":"72","author":"Rizzolio","year":"2012","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.canlet.2024.217302_bib25","doi-asserted-by":"crossref","first-page":"13457","DOI":"10.1074\/jbc.M410924200","article-title":"Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2","volume":"280","author":"West","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.canlet.2024.217302_bib26","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1242\/bio.010918","article-title":"VEGF-A\/NRP1 stimulates GIPC1 and Syx complex formation to promote RhoA activation and proliferation in skin cancer cells","volume":"4","author":"Yoshida","year":"2015","journal-title":"Biol. open"},{"issue":"1","key":"10.1016\/j.canlet.2024.217302_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000025","article-title":"Neuropilin-1\/GIPC1 signaling regulates \u03b15\u03b21 integrin traffic and function in endothelial cells","volume":"7","author":"Valdembri","year":"2009","journal-title":"PLoS Biol."},{"issue":"3","key":"10.1016\/j.canlet.2024.217302_bib28","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3390\/ijms20030639","article-title":"Neuropilins in the context of tumor vasculature","volume":"20","author":"Niland","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.canlet.2024.217302_bib29","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3390\/cancers11050692","article-title":"Role of integrins in resistance to therapies targeting growth factor receptors in cancer","volume":"11","author":"Cruz da Silva","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2024.217302_bib30","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s12094-013-1141-y","article-title":"Neuropilin-1 is overexpressed in osteosarcoma and contributes to tumor progression and poor prognosis","volume":"16","author":"Zhu","year":"2014","journal-title":"Clin. Transl. Oncol."},{"issue":"16","key":"10.1016\/j.canlet.2024.217302_bib31","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1158\/1078-0432.CCR-07-0001","article-title":"Targeting neuropilin 1 as an antitumor strategy in lung cancer","volume":"13","author":"Hong","year":"2007","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.canlet.2024.217302_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27368","article-title":"Bioinformatics analysis and clinical significance of NRP-1 in triple-negative breast cancer","volume":"10","author":"Ma","year":"2024","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.canlet.2024.217302_bib33","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/MPA.0000000000000117","article-title":"High neuropilin 1 expression was associated with angiogenesis and poor overall survival in resected pancreatic ductal adenocarcinoma","volume":"43","author":"Ben","year":"2014","journal-title":"Pancreas"},{"issue":"5","key":"10.1016\/j.canlet.2024.217302_bib34","first-page":"2460","article-title":"NRP1 promotes cell migration and invasion and serves as a therapeutic target in nasopharyngeal carcinoma","volume":"11","author":"Huang","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"12","key":"10.1016\/j.canlet.2024.217302_bib35","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.7150\/jca.52851","article-title":"Neuropilin-1 predicts poor prognosis and promotes tumor metastasis through epithelial-mesenchymal transition in gastric cancer","volume":"12","author":"Jin","year":"2021","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2024.217302_bib36","first-page":"349","article-title":"NRP1-positive lung cancer cells possess tumor-initiating properties","volume":"39","author":"Jimenez-Hernandez","year":"2018","journal-title":"Oncol. Rep."},{"issue":"9","key":"10.1016\/j.canlet.2024.217302_bib37","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1002\/ijc.27475","article-title":"Imaging the inhibition by anti\u2010\u03b21 integrin antibody of lung seeding of single osteosarcoma cells in live mice","volume":"131","author":"Kimura","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.canlet.2024.217302_bib38","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1158\/2159-8290.CD-20-1230","article-title":"St. Jude Cloud: a pediatric cancer genomic data-sharing ecosystem","volume":"11","author":"McLeod","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2024.217302_bib39","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ijbiomac.2018.11.003","article-title":"NF-\u03baB signaling and integrin-\u03b21 inhibition attenuates osteosarcoma metastasis via increased cell apoptosis","volume":"123","author":"Li","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.canlet.2024.217302_bib40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejca.2022.09.007","article-title":"Osteosarcoma and causes of death: a report of 1520 deceased patients from the Cooperative Osteosarcoma Study Group (COSS)","volume":"176","author":"Bielack","year":"2022","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.canlet.2024.217302_bib41","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/cncr.29858","article-title":"SARC009: phase 2 study of dasatinib in patients with previously treated, high\u2010grade, advanced sarcoma","volume":"122","author":"Schuetze","year":"2016","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2024.217302_bib42","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4161\/cc.10.3.14712","article-title":"Distinct and redundant functions of histone deacetylases HDAC1 and HDAC2 in proliferation and tumorigenesis","volume":"10","author":"Jurkin","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2024.217302_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119504","article-title":"Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy","volume":"277","author":"Ramaiah","year":"2021","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.canlet.2024.217302_bib44","doi-asserted-by":"crossref","first-page":"a026831","DOI":"10.1101\/cshperspect.a026831","article-title":"HDACs and HDAC inhibitors in cancer development and therapy","volume":"6","author":"Li","year":"2016","journal-title":"Cold Spring Harbor Perspect. Med."},{"issue":"1","key":"10.1016\/j.canlet.2024.217302_bib45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.molcel.2008.02.030","article-title":"Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control","volume":"30","author":"Bhaskara","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2024.217302_bib46","article-title":"The roles of histone deacetylases and their inhibitors in cancer therapy","volume":"8","author":"Li","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2024.217302_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.700947","article-title":"Characterization of histone deacetylase mechanisms in cancer development","volume":"11","author":"Hai","year":"2021","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.canlet.2024.217302_bib48","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41419-022-04571-9","article-title":"Suppression of histone deacetylase 1 by JSL-1 attenuates the progression and metastasis of cholangiocarcinoma via the TPX2\/Snail axis","volume":"13","author":"Xu","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.canlet.2024.217302_bib49","first-page":"1","article-title":"HDAC1 promotes the migration of human myeloma cells via regulation of the lncRNA\/Slug axis","volume":"49","author":"Zheng","year":"2022","journal-title":"Int. J. Mol. Med."},{"issue":"8","key":"10.1016\/j.canlet.2024.217302_bib50","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4161\/cbt.6.8.4363","article-title":"Neuropilin-1 interacts with integrin \u03b21 and modulates pancreatic cancer cell growth, survival and invasion","volume":"6","author":"Fukasawa","year":"2007","journal-title":"Cancer Biol. Ther."},{"issue":"12","key":"10.1016\/j.canlet.2024.217302_bib51","article-title":"Knockdown of neuropilin-1 suppresses invasion, angiogenesis, and increases the chemosensitivity to doxorubicin in osteosarcoma cells--an in vitro study","volume":"18","author":"Yue","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"21","key":"10.1016\/j.canlet.2024.217302_bib52","doi-asserted-by":"crossref","first-page":"10309","DOI":"10.1158\/0008-5472.CAN-07-3256","article-title":"Hepatocyte growth factor\u2013mediated cell invasion in pancreatic cancer cells is dependent on Neuropilin-1","volume":"67","author":"Matsushita","year":"2007","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.canlet.2024.217302_bib53","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1183\/09031936.98.11020400","article-title":"Integrin dependent migration of lung cancer cells to extracellular matrix components","volume":"11","author":"Bredin","year":"1998","journal-title":"Eur. Respir. J."},{"issue":"41","key":"10.1016\/j.canlet.2024.217302_bib54","doi-asserted-by":"crossref","first-page":"E8685","DOI":"10.1073\/pnas.1701821114","article-title":"Cross-activating c-Met\/\u03b21 integrin complex drives metastasis and invasive resistance in cancer","volume":"114","author":"Jahangiri","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2024.217302_bib55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/978-1-4615-0119-0_5","article-title":"Structural and functional relation of neuropilins","author":"Nakamura","year":"2002","journal-title":"Neuropilin: From Nervous Syst. Vascul. Tumor Biol."},{"issue":"1","key":"10.1016\/j.canlet.2024.217302_bib56","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1158\/2159-8290.CD-19-0384","article-title":"Circulating tumor cells exhibit metastatic tropism and reveal brain metastasis drivers","volume":"10","author":"Klotz","year":"2020","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.canlet.2024.217302_bib57","article-title":"Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy","volume":"8","author":"Chuckran","year":"2020","journal-title":"J. Immun.Ther. Cancer"},{"issue":"5","key":"10.1016\/j.canlet.2024.217302_bib58","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/CM9.0000000000001200","article-title":"Targeting neuropilin-1 interactions is a promising anti-tumor strategy","volume":"134","author":"Liu","year":"2021","journal-title":"Chinese Med J"},{"key":"10.1016\/j.canlet.2024.217302_bib59","first-page":"2020","article-title":"Results of a randomized, double-blinded, placebo-controlled, phase 2.5 study of saracatinib (AZD0530), in patients with recurrent osteosarcoma localized to the lung","author":"Baird","year":"2020","journal-title":"Sarcoma"},{"issue":"5","key":"10.1016\/j.canlet.2024.217302_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152621","article-title":"Outcomes of adolescent and adult patients with lung metastatic osteosarcoma and comparison of synchronous and metachronous lung metastatic groups","volume":"11","author":"Gok Durnali","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.canlet.2024.217302_bib61","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/cncr.32777","article-title":"An evolutionary framework for treating pediatric sarcomas","volume":"126","author":"Reed","year":"2020","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.canlet.2024.217302_bib62","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3390\/cells8090991","article-title":"MMP14 in sarcoma: a regulator of tumor microenvironment communication in connective tissues","volume":"8","author":"Gonzalez-Molina","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2024.217302_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2049-3002-1-7","article-title":"Metabolic changes in cancer cells upon suppression of MYC","volume":"1","author":"Anso","year":"2013","journal-title":"Cancer Metabol."},{"issue":"7_Supplement","key":"10.1016\/j.canlet.2024.217302_bib64","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2023-276","article-title":"Delineating the role of vesicular glutamate transporter SLC17A7 in osteosarcoma","volume":"83","author":"Nerlakanti","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2024.217302_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40170-020-0209-8","article-title":"Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcoma","volume":"8","author":"Ren","year":"2020","journal-title":"Cancer Metabol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524006979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383524006979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:25:22Z","timestamp":1731716722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383524006979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":65,"alternative-id":["S0304383524006979"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217302","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histone deacetylase upregulation of neuropilin-1 in osteosarcoma is essential for pulmonary metastasis","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2024.217302","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"217302"}}